Patent Funded Access to Medicines

Developing World Bioethics 15 (3):152-161 (2015)

Abstract
Instead of impeding access to essential medicines in developing countries, the essay explores why and how patents can serve as a source of funding for the much needed access to medicine. Instead of a weakening of patents, prolonged protection periods are suggested in circumstances where there is widespread lack of access. The revenues from extended patents are seen as a source of funding for drug donations to the least developed countries
Keywords pharmaceutical patents rights  health  international justice  distributive justice  developing world  medical ethics
Categories (categorize this paper)
DOI 10.1111/dewb.12058
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 43,883
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

A Critique in Need of Critique.M. Peterson, A. Hollis & T. Pogge - 2010 - Public Health Ethics 3 (2):178-185.

View all 10 references / Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Can Drug Patents Be Morally Justified?Dr Sigrid Sterckx - 2005 - Science and Engineering Ethics 11 (1):81-92.
Can Drug Patents Be Morally Justified?Sigrid Sterckx - 2005 - Science and Engineering Ethics 11 (1):81-92.
Are Pharmaceutical Patents Protected by Human Rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.
Fair Drug Prices and the Patent System.David B. Resnik - 2004 - Health Care Analysis 12 (2):91-115.
Surgical Patents and Patients — the Ethical Dilemmas.Tadeusz Tołłoczko - 2005 - Science and Engineering Ethics 11 (1):61-69.
Patents and Human Rights: A Heterodox Analysis.E. Richard Gold - 2013 - Journal of Law, Medicine and Ethics 41 (1):185-198.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.

Analytics

Added to PP index
2014-04-21

Total views
24 ( #360,620 of 2,266,258 )

Recent downloads (6 months)
8 ( #144,326 of 2,266,258 )

How can I increase my downloads?

Downloads

My notes

Sign in to use this feature